Literature DB >> 28765322

Structural Basis and Genotype-Phenotype Correlations of INSR Mutations Causing Severe Insulin Resistance.

Jun Hosoe1, Hiroko Kadowaki2, Fuyuki Miya1,3,4,5, Katsuya Aizu6, Tomoyuki Kawamura7, Ichiro Miyata8, Kenichi Satomura9, Takeru Ito10, Kazuo Hara11, Masaki Tanaka12, Hiroyuki Ishiura12, Shoji Tsuji12, Ken Suzuki1, Minaka Takakura1, Keith A Boroevich4, Tatsuhiko Tsunoda3,4,5, Toshimasa Yamauchi1, Nobuhiro Shojima13, Takashi Kadowaki13.   

Abstract

The insulin receptor (INSR) gene was analyzed in four patients with severe insulin resistance, revealing five novel mutations and a deletion that removed exon 2. A patient with Donohue syndrome (DS) had a novel p.V657F mutation in the second fibronectin type III domain (FnIII-2), which contains the α-β cleavage site and part of the insulin-binding site. The mutant INSR was expressed in Chinese hamster ovary cells, revealing that it reduced insulin proreceptor processing and impaired activation of downstream signaling cascades. Using online databases, we analyzed 82 INSR missense mutations and demonstrated that mutations causing DS were more frequently located in the FnIII domains than those causing the milder type A insulin resistance (P = 0.016). In silico structural analysis revealed that missense mutations predicted to severely impair hydrophobic core formation and stability of the FnIII domains all caused DS, whereas those predicted to produce localized destabilization and to not affect folding of the FnIII domains all caused the less severe Rabson-Mendenhall syndrome. These results suggest the importance of the FnIII domains, provide insight into the molecular mechanism of severe insulin resistance, will aid early diagnosis, and will provide potential novel targets for treating extreme insulin resistance.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28765322     DOI: 10.2337/db17-0301

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

Review 1.  Monogenic diabetes: a gateway to precision medicine in diabetes.

Authors:  Haichen Zhang; Kevin Colclough; Anna L Gloyn; Toni I Pollin
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

Review 2.  Severe insulin resistance syndromes.

Authors:  Angeliki M Angelidi; Andreas Filippaios; Christos S Mantzoros
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

3.  Clinical and Functional Characterization of Novel INSR Variants in Two Families With Severe Insulin Resistance Syndrome.

Authors:  Qiaoli Zhou; Jing Yu; Xuewen Yuan; Chunli Wang; Ziyang Zhu; Aihua Zhang; Wei Gu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-29       Impact factor: 5.555

4.  Adrenocortical hypofunction with simultaneous primary aldosteronism: A case report.

Authors:  Kaiyong Liang; Xiaojuan Ou; Xukai Huang; Qunfang Lan
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 5.  Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors' Expert Forum.

Authors:  Matthew C Riddle; Louis H Philipson; Stephen S Rich; Annelie Carlsson; Paul W Franks; Siri Atma W Greeley; John J Nolan; Ewan R Pearson; Philip S Zeitler; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2020-12       Impact factor: 19.112

6.  DNA methylation of the INSR gene as a mediator of the association between prenatal exposure to famine and adulthood waist circumference.

Authors:  Zhenghe Wang; Jieyun Song; Changwei Li; Yanhui Li; Luqi Shen; Bin Dong; Zhiyong Zou; Jun Ma
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

7.  Clinical characteristics of insulin resistance syndromes: A nationwide survey in Japan.

Authors:  Takehito Takeuchi; Yasushi Ishigaki; Yushi Hirota; Yutaka Hasegawa; Tohru Yorifuji; Hiroko Kadowaki; Takashi Akamizu; Wataru Ogawa; Hideki Katagiri
Journal:  J Diabetes Investig       Date:  2019-12-05       Impact factor: 4.232

Review 8.  Insulin action at a molecular level - 100 years of progress.

Authors:  Morris F White; C Ronald Kahn
Journal:  Mol Metab       Date:  2021-07-15       Impact factor: 8.568

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.